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53 Aims: 
54 To secure adequate carbohydrate supply in pregnancy, the Institute of Medicine (IOM) recommends 
55 a minimum amount of carbohydrates of 175 g daily. Currently a low carbohydrate diet is a popular 
56 health trend in the general population and this might also be common among overweight and obese 
57 pregnant women with type 2 diabetes (T2D). Thus, we explored carbohydrate consumption among 
58 pregnant women with T2D including women with type 1 diabetes (T1D) for comparison.
59
60 Methods: 
61 A retrospective cohort study of consecutive women with T2D (N=96) and T1D (N=108), where 
62 dietary records were collected at the first antenatal visit.
63
64 Results: 
65 Among women with T2D and T1D, bodyweight at the first visit was 90.8±22 (mean±SD) and 
66 75.5±15 kg (P<0.001) while HbA1c was 6.6±1.2% (49±13 mmol/mol) and 6.6±0.8% (48±8 
67 mmol/mol), P=0.8, respectively. The average daily carbohydrate consumption from the major 
68 carbohydrate sources was similar in the two groups (159±56 and 167±48 g, P=0.3), as was the level 
69 of total daily physical activity (median (interquartile range)): 215 (174-289) and 210 (178-267) 
70 metabolic equivalent of task-hour/week (P=0.9). A high proportion of women with T2D and T1D 
71 (52% and 40%, P=0.08) consumed fewer carbohydrates than recommended by the IOM. The 
72 prevalence of ketonuria (≥4 mmol/L) was 1% in both groups.
73
74 Conclusions: 
75 In early pregnancy, a lower daily carbohydrate consumption than recommended by the IOM was 
76 common among women with T2D. The results were quite similar to women with T1D, despite a 
77 markedly higher bodyweight in women with T2D. Reassuringly, ketonuria was rare in both groups.
78
79 Keywords: Carbohydrate, pregnancy, type 2 diabetes, type 1 diabetes.
80
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81 1. Introduction
82 Pregnancies complicated by diabetes are associated with increased risk of adverse perinatal 
83 outcomes including infants born large for gestational age (1,2). This is mostly attributed to the 
84 maternal transfer of excessive glucose across the placenta leading to accelerated fetal growth (3). 
85 The total amount of carbohydrates is the main dietary factor affecting postprandial blood glucose 
86 (4). Therefore a restricted carbohydrate consumption in pregnant women with diabetes could be 
87 sensible but as both the maternal and the fetal brain mainly use glucose as an energy source, the 
88 Institute of Medicine (IOM) and the American Diabetes Association (ADA) recommend a 
89 minimum of 175 g of carbohydrates daily for pregnant women (5,6). The average daily 
90 carbohydrate consumption in early pregnancy in healthy women is in general reported to be well 
91 above the minimum amount recommended by the IOM (7,8) and excessive gestational weight gain 
92 is common (9).
93 A low carbohydrate diet aiming at reducing plasma glucose levels and obtaining weight loss is a 
94 popular health trend in the general population (10) and in patients with type 2 diabetes (T2D) (11) 
95 but may be harmful during pregnancy. Insufficient carbohydrate consumption can lead to increased 
96 lipolysis and ketone body production and pregnant women are in general more prone to ketosis than 
97 non-pregnant women (12-14). Previous observational studies in offspring of women with diabetes 
98 suggests that elevated maternal ketone bodies may have a negative effect on the developing fetal 
99 central nervous system (15,16). Thus, we speculate that, in pregnant women with diabetes, 
100 sufficient daily carbohydrate consumption and avoidance of ketonemia are probably important for 
101 normal fetal brain development.
102 The total amount of macronutrients required to maintain body weight is dependent on the body 
103 composition and the level of physical activity. Therefore, the recommendations on carbohydrate 
104 consumption are often given per kilo bodyweight which probably can lead to inappropriately high 
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105 carbohydrate consumption in obese women where the recommended gestational weight gain is 
106 smaller than in normal weight women (14). High prevalence of excessive gestational weight gain 
107 has been reported among pregnant women with diabetes (17-19). Recommendations on lower 
108 energy percent (E%) of carbohydrates in obese pregnant women with diabetes has been suggested 
109 (20).
110 Modern diabetes treatment respects a flexible lifestyle (21) and the daily amount of carbohydrates 
111 varies considerably from day to day in pregnant women with type 1 diabetes (T1D) (22). In a real 
112 world, daily dietary intake may therefore vary considerably from the dietary advises given. One 
113 small study including 19 women with T2D at 22 gestational weeks found an average carbohydrate 
114 consumption of 259 g daily (23). Sufficient intake of lipids and proteins as well as micronutrients 
115 during pregnancy is also important for fetal growth (24), but this study is restricted to carbohydrate 
116 consumption.
117 In a real-world setting, we aimed to explore carbohydrate consumption and prevalence of ketonuria 
118 in early pregnancy among women with T2D including women with T1D for comparison.
119 2. Subjects, Materials and Methods
120 2.1 Study population
121 As a part of routine care since January 2013, all pregnant women referred to Center for Pregnant 
122 Women with Diabetes at Rigshospitalet have been asked to fill out a 3-day dietary record focusing 
123 on carbohydrates before their first antenatal visit at the centre. Thus, a dietary record form was sent 
124 to the women along with a welcome letter by mail. The inclusion criteria in this retrospective cohort 
125 study from August 2013 to September 2017 were: women with T2D or T1D, Danish speaking, 
126 singleton pregnancy and first antenatal visit before 20 gestational weeks. Aiming for a comparable 
127 number of women in the two diabetes groups and since data on carbohydrate consumption in 
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128 pregnant women with T1D have already been published for the period January 2013 to December 
129 2014 (22), we decided to include women with T1D from January 2015 to September 2017.
130 In the inclusion period the following women did not meet the inclusion criteria: not-Danish 
131 speaking (n=47 with T2D and n=1 with T1D), multifetal pregnancy (n=10 and n=8), first antenatal 
132 visit later than 20 gestational weeks (n=20 and n=2) and 5 (n=4 and n=1) with previous bariatric 
133 surgery, resulting in 171 eligible women with T2D and 248 with T1D of which 96 (56%) and 108 
134 (44%), respectively had completed the dietary records.
135 2.2 Dietary analysis
136 At the first antenatal visit, all women had a one-hour appointment with a specialized dietician who 
137 used the information from the dietary records as a basis for individualized dietary advice. Based on 
138 the dietary records, the dietician counted the recorded carbohydrates and used validated tables (25), 
139 photos (26) and a carbohydrate counting app, recommended by the Danish Diabetes Association,  
140 when needed. The quantity of the carbohydrates was calculated from the major carbohydrate 
141 sources only, i.e. bread products, potatoes, rice, pasta, fruits, dairy products and sweets. The major 
142 carbohydrate sources account for the majority of carbohydrates consumed e.g. a commonly 
143 recommended Danish diabetes diet for women, regardless of pregnancy, contains 1612 kcal (6743 
144 kJ) including 175 g of carbohydrates in total (46 E%). Of those the major carbohydrate sources 
145 account for 86% (150 g) of the total amount of carbohydrates while 700 g of vegetables account for 
146 the remaining 25 g of carbohydrates. A pragmatic evaluation of the glycaemic index (27) based on 
147 an calculation of the total daily carbohydrate consumption was performed by the dietician in the 
148 following way: The amount of carbohydrates from low glycaemic index sources was identified and 
149 divided by the total amount of carbohydrates consumed. We stratified the glycaemic index score as 
150 0-33%, 34-66% or 67-100% of carbohydrates deriving from low glycaemic index sources. 
151 Furthermore, the number of meals and snacks consumed daily and whether the women used 
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152 carbohydrate counting in each meal and snack (yes/no) were registered, whereas total E%, 
153 glycaemic load, lipid- and protein consumption were not assessed.
154 In Denmark, the recommended diet for women with diabetes, regardless of pregnancy, consists of 
155 approximately 55 E% of carbohydrates mainly from low glycaemic index sources with high amount 
156 of fibres (28,29). In general, individualized dietary plans including 3 main meals and 2-3 snacks are 
157 tailored with respect of the women’s eating habits, cultural, ethnical and economic status and 
158 presence of nausea  (28,30). With the aim to prevent excessive gestational weight gain and by 
159 assuming that eating more than recommended is frequent, a total daily energy intake of 
160 approximately 1673 kcal (7000 kJ) regardless of pre-pregnancy BMI or trimester is recommended 
161 for pregnant women with diabetes at our centre. The recommendation includes at least 175 g of 
162 carbohydrates with 150 g deriving from the major carbohydrate sources. The initially recommended 
163 total energy intake can be upregulated during pregnancy according to individual needs including 
164 changes in the level of physical activity aiming for appropriate weekly gestational weight gain 
165 without hunger or ketonuria. To secure sufficient intake of micro- and macronutrients, a reduction 
166 in the total energy intake is not recommended and it is our experience that upregulating the 
167 recommended energy intake is seldomly needed.
168 2.3 Questionnaire on physical activity and early pregnancy events
169 Since 2015, the women were asked to answer a questionnaire at first antenatal visit. The 
170 questionnaire included a validated Pregnancy Physical Activity Questionnaire (PPAQ) (31) 
171 consisting of 33 questions grouped into different types of activity (i.e. household/caregiving, 
172 occupation, sports). The women could add two physical activities not listed in the questionnaire, 
173 where the intensities were individually estimated using the Compendium of Physical Activity (32). 
174 In Denmark, bicycling is very common and therefore two questions were added into the 
175 questionnaire, one on bicycling as transportation and one on bicycling as leisure activity (33). For 
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176 each of the 35 questions, the duration of time spent in each activity was multiplied by the intensity 
177 to get the average weekly energy expenditure (metabolic equivalent of task per hour (METs-
178 hr.)/wk.). The questionnaire also included non-validated questions about number of times where the 
179 women had eaten extra snacks due to hypoglycaemia the previous week, number of times where the 
180 women had eaten less or more due to nausea the previous week, number of episodes of vomiting in 
181 the previous week, number of weekly blood glucose measurements before pregnancy as well as 
182 during the previous week and average number of sleeping hours. Fifty-two percent of women with 
183 T2D and 39% of women with T1D, answered this questionnaire at first antenatal visit.
184 2.4 Demographic and clinical data
185 Demographic and clinical data were collected from two standardized forms in the original medical 
186 records.
187 HbA1c was measured at the first antenatal visit in capillary blood and analysed immediately by a 
188 DCA 2000 analyser by a latex immunoagglutination inhibition method (DCA 200; Bayer, 
189 Mishawaka, IN). Early gestational weight gain was defined as the weight measured at the first 
190 antenatal visit minus self-reported weight before pregnancy (kg). Spot urine samples were collected 
191 at the clinic in the morning hours of the visits. The occurrence of ketonuria was noted if the 
192 concentration of ketone bodies was ≥4.0 mmol/L, detected on a dipstick of sterile urine (analysed 
193 by Siemens CLINITEK Status® + Analyzer). If urine ketone bodies ≥4.0 mmol/L were detected, 
194 blood ketone bodies were routinely measured (FreeStyle Precision, Abbott). Urine ketone body 
195 levels of 4.0-7.9 mmol/L corresponding to +3 on the dipstick was equivalent to a median (range) 
196 blood ketone body level of 0.2 (0-0.8) mmol/L (N=18) (unpublished data from our department). 
197 2.5 Routine diabetes care
198 In Denmark, most non-pregnant women T2D receive diabetes treatment in general practice, while 
199 women with T1D are treated at local diabetes centres. The national recommendations for routine 
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200 diabetes care aim for HbA1c ≤7.0 % (53 mmol/mol) before pregnancy and ≤6.5 % (48 mmol/mol) 
201 in early pregnancy (34). The majority of women with T2D are treated with diet alone or in a 
202 combination with oral antidiabetic drugs and/or injections with Glucagon-like Peptide-1 analogue 
203 before pregnancy until pregnancy planning or at the latest up to the first antenatal visit where the 
204 treatment is changed to an insulin regimen.
205 2.6 Statistical analysis
206 Continuous data with normal distribution are reported as mean (± standard deviation (SD)), 
207 continuous data with skewed distribution as median (interquartile range (IQR)) and categorical data 
208 as number (%). Descriptive results are given for T2D and T1D separately. Comparisons of the 
209 groups were performed by student‘s t-test, Mann-Whitney U-test, Chi square test or Fisher‘s exact 
210 tests when appropriate. 
211 Since the carbohydrate recommendations and carbohydrate consumption during pregnancy were 
212 similar for women with T2D and T1D, univariate regression analysis was performed in the 
213 combined cohort (T2D and T1D) as well as in the individual diabetes groups.  In the univariate 
214 linear regression analyses the carbohydrate consumption per 100 g was used as an independent 
215 variable and HbA1c (%) as an outcome variable. 
216 The multivariate regression analysis was performed in the combined cohort only, using 
217 carbohydrate consumption per 100 g as independent variable and HbA1c (%) as an outcome 
218 variable with the following potential confounders; maternal age, pre-gestational BMI, daily insulin 
219 dose/bodyweight (IU/kg/24h), treatment with insulin pump (yes/no) and type of diabetes (T2D and 
220 T1D). The results of the linear regression analyses are given as the regression coefficient beta (β) 
221 with a 95% confidence interval (CI), expressing the change in the outcome variable for a unit 
222 change in the independent variable.
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223 Statistical analyses were performed with IBM statistics SPSS version 22. Statistically significant 
224 differences were defined as a two-sided p <0.05.
225 2.7 Ethics
226 Approvals from the local Ethic committee (H-15009413) and the Danish Data Protection Agency 
227 (2007-58-0015 and 2012-58-0004) were obtained and all patients gave informed consent as 
228 appropriate according to Danish laws. The principles of The Helsinki Declaration were observed.
229 3. Results
230 Clinical characteristics at first antenatal visit are given in Table 1. The mean HbA1c was 
231 comparable in early pregnancy, while the women with T2D had higher prepregnancy BMI and 
232 lower weekly gestational weight gain prior to first antenatal visit than the women with T1D. 
233 Daily carbohydrate consumption was similar in the women with T2D vs. T1D (159 ±56 vs. 167 ±48 
234 g, P=0.3) with a carbohydrate consumption per bodyweight of 1.9 ±0.9 vs. 2.3 ±0.8 g/kg, P<0.001, 
235 respectively (Table 2). Fifty-two percent of the women with T2D and 40% of the women with T1D 
236 consumed fewer carbohydrates than recommended by the IOM (P=0.08) (Table 2). In the combined 
237 group of women with diabetes, the women who consumed fewer carbohydrates than recommended 
238 by the IOM had comparable HbA1c (6.5 ±1.0% (48 ±11 mmol/mol) vs. 6.6 ±1.0% (49 ±11 
239 mmol/mol), P=0.5) but lower weekly gestational weight gain (126 (13-260) vs. 200 (67-377) g, 
240 P=0.02) than the women following the IOM recommendations. Ten (10%) women with T2D and 8 
241 (7%) women with T1D reported consuming <100 g of carbohydrates daily (Table 2) with a mean 
242 daily consumption of 83 and 78 g, respectively. None of these 18 women had ketonuria at first 
243 antenatal visit. Daily carbohydrate consumption >200 g was reported by 16 (17%) women with 
244 T2D and 20 (19%) women with T1D.
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245 Among women with T2D the glycaemic index score of the carbohydrates was less favourable 
246 compared with women with T1D (P=0.04) and carbohydrate counting was less frequently used 
247 (Table 2). 
248 In an univariate linear regression analysis, a significant association between daily carbohydrate 
249 consumption and HbA1c could not be detected in neither the combined cohort (β:0.13 (95% CI: -
250 0.1-0.4) %, P=0.3) or when calculated separately for the women with T2D (β:0.2 (95% CI: -0.2-0.6) 
251 %, P=0.4) and T1D (β:0.04 (95% CI: -0.3-0.4) %, P=0.8). Similar no association was found in the 
252 multiple regression analysis.
253 One woman with T2D and one woman with T1D had ketonuria with urine ketone concentration of 
254 4.0-7.9 mmol/L at first antenatal visit (Table 1). The mean carbohydrate consumption was reported 
255 to be 160 g/day and 121 g/day, respectively, and only the woman with T2D had a bedtime snack.
256 Data on physical activity was available in a subgroup of 56% vs. 38% patients, respectively. The 
257 total physical activity level was comparable in women with T2D and T1D (Table 3). The women 
258 with T2D spent significantly more energy on household/caregiving than the women with T1D while 
259 no difference between the groups was found in energy expenditure during occupation and sports 
260 (Table 3). A higher energy expenditure during household/caregiving was found among multipara 
261 compared to nullipara (100 (66-140) vs. 49 (30-70) METs-hr./wk., P<0.001).
262 Insulin treated women with T2D reported consuming extra carbohydrates due to episodes of 
263 hypoglycaemia twice weekly while women with T1D consumed extra carbohydrates 5.5 times/week 
264 (Table 3).
265 Nausea leading to eating less or more food during the previous week was reported by 54% of the 
266 women with T2D and 64% of the women with T1D (Table 3). Nauseous women consumed 165 ±50 
267 g of carbohydrates daily, while women without nausea consumed 148 ±56 g daily (P=0.1).
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268 Among the women with T2D, a high number were of non-North-European Origin. The 
269 carbohydrate consumption in the women with T2D of North-European origin was comparable with 
270 women of non-North-European origin (165 ±60 vs. 154 ±53 g, P=0.4) as was the number of women 
271 consuming ≤150 g carbohydrates daily (46% vs. 58%, P=0.3). HbA1c was 6.8 ±1.3% (51 ±14 
272 mmol/mol) vs. 6.4 ±1% (47 ±11 mmol/mol) P=0.2, in women of North-European origin vs. non-
273 North-European origin.
274 4. Discussion
275 This cohort study from Denmark, in a real-world setting, demonstrates that the women with T2D 
276 often consumed fewer carbohydrates than recommended by the IOM in early pregnancy. The 
277 average carbohydrate consumption from the major carbohydrate sources was similar in women with 
278 T2D and T1D. Women with T2D weighted on average 15.3 kg more than women with T1D and 
279 ketonuria in early pregnancy was rare in both groups.
280 The average carbohydrate consumption in this study was lower than previously described for 
281 women with T2D (23), T1D (22) and healthy pregnant women where 286 and 393 g daily has been 
282 reported (7,8), even if the expected 25 g from the minor sources is added. In healthy women, 
283 carbohydrate consumption throughout pregnancy has been reported rather stable with an average 
284 4% higher consumption in late pregnancy (7,8,35). In both our and the Canadian study (23), the 
285 average carbohydrate consumption was similar in women with T2D and T1D while the bodyweight 
286 was approximately 15 kg higher in women with T2D. This may reflect similar intake of the total 
287 energy or a different distribution in the macronutrient consumption with higher fat and/or protein 
288 intake in obese women compared with normal weight women.  
289 The minimum amount of carbohydrates required to prevent ketosis is 50 to 100 g daily outside of 
290 pregnancy (36). During third trimester, the fetal brain is estimated to use approximately 35 g of 
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291 carbohydrates per day as an energy source  (6) and additional carbohydrates are used for fetal 
292 growth.
293 A high proportion of women in our study reported an intake of fewer carbohydrates than 
294 recommended by the IOM. Older studies have raised concern about the adverse effect of ketone 
295 bodies on the developing fetal brain in pregnancies complicated with diabetes (15,16). An inverse 
296 correlation between the mothers’ third trimester plasma β-hydroxybutyrate and children’s 
297 intelligence both at the age of 2 and 3-5 years has been reported (15). A recent study from our own 
298 group reported lower intelligence in teenage offspring of mothers suffering from ketoacidosis 
299 during pregnancy, but numbers were small (37). Therefore, it is reassuring that the occurrence of 
300 ketonuria in early pregnancy was low in the present study. 
301 In contrast to our previous findings (22), we did not observe an association between carbohydrate 
302 consumption and HbA1c in this cohort. This may be due to a lower number of women with a 
303 carbohydrate consumption exceeding 200 g daily and less variation in HbA1c in the present cohort. 
304 Carbohydrate counting is important to obtain tight glycaemic control with a flexible lifestyle in 
305 patients with T1D who do not have an endogenous insulin production (22,38) and was frequently 
306 used in the investigated women. Carbohydrate counting in women with T2D was rare and whether 
307 pregnant women with T2D also benefit from carbohydrate counting needs to be investigated. 
308 To our knowledge, this is the largest study to date, evaluating the carbohydrate consumption in 
309 early pregnancy as part of routine care in a cohort of women with T2D in a real-world setting, 
310 including data on ketonuria, nausea and vomiting. The evaluation of the carbohydrate consumption 
311 is meaningful for insulin treated patients and diabetes caregivers. The same dietician (HR) 
312 evaluated the amount of carbohydrates consumed and the glycaemic index score which gives 
313 consistency of the method.
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314 It is a limitation that the women’s carbohydrate consumption was self-reported and the total E%, 
315 glycaemic load, lipid- and protein consumption were not recorded. To minimize the recall bias, the 
316 women were asked to complete the dietary records prospectively over 3 days before the first 
317 antenatal visit. The women may have chosen a healthier diet during the dietary registration and/or 
318 omitted to register all carbohydrates from the major carbohydrates consumed. It is known that less 
319 healthy eaters are more likely to underreport food intake (39). Despite these limitations, this is one 
320 of the best options for evaluation of carbohydrate consumption in a large population. All eligible 
321 women reporting at least one day of dietary records were included in the study to improve the 
322 external validity of the study, but this might have biased the estimation of the daily carbohydrate 
323 consumption. It would have added value to our study, if the women had tested for ketonuria at 
324 home the same days as the dietary registration. There is a risk of selection bias as the less compliant 
325 women with unhealthy eating habits may not have filled out the dietary records. Data from the 
326 PPAQ was only available in 52% and 39% of included women with T2D and T1D, respectively.
327 4.1 Conclusions
328 In early pregnancy, a lower daily carbohydrate consumption than recommended by the IOM was 
329 common among women with T2D. The results were quite similar to women with T1D, despite a 
330 markedly higher bodyweight in women with T2D. Reassuringly, ketonuria was rare in both groups. 
331 Future studies should focus on the safety of consuming a low amount of carbohydrates during 
332 pregnancy in women with diabetes.
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458 Table 1. Clinical characteristics of pregnant women with type 2 diabetes compared with pregnant 
459 women with type 1 diabetes at first antenatal visit. 
Type 2 diabetes Type 1 diabetes P-value
Number 96 108
Age (years) 34 ±5 31 ±5 0.001
Duration of diabetes (years) 3 (1-6) 16 (9-22) <0.001
Prepregnancy weight (kg) 89.5 ±23 73.4 ±15 <0.001
Prepregnancy diet treatment only 23 (24%)
Prepregnancy oral antidiabetic medication† 60 (63%)
Prepregnancy treatment with Glucagon-Like-
Peptide-1-antagonist‡
9 (9%)
Height (cm) 165 ±7 168 ±6 0.001
Prepregnancy BMI (kg/m2) 32.8 ±7 26.0 ±5 <0.001
North-European Origin 52 (55%) 98 (93%) <0.001 
Nulliparous 36 (38%) 55 (51%) 0.06
Smoking 2/49 (4%) 1/43 (2%) 0.6
Gestational age (days) 71 (60-87) 63 (56-76) 0.003
HbA1c (%)  
            (mmol/mol)
6.6 ±1.2
49 ±13
6.6 ±0.8
48 ±8
0.8
Insulin treatment 18 (19%) 108 (100%) -
Insulin pump treatment 0% 36 (33%) -
Insulin dose (IU/kg/24h)§ 0.67 ±0.40 0.61 ±0.28 0.6
Weight (kg) 90.8 ±22 75.5 ±15 <0.001
Early gestational weight gain (kg) 1.5 ±2.7 2.1 ±2.1 0.07
Early weekly gestational weight gain (g) 145 ±247 233 ±230 0.01
Ketonuria (≥4.0 mmol/L) 1 (1%) 1 (1%) 1.0
460 Data are given as mean ±standard deviation, median (interquartile range) or n (%). †Monotherapy with Biguanide 
461 (N=39). Combination therapy with Biguanide and Glucagon-Like-Peptide-1-antagonist (GLP-1-antagonist) (N=6), 
462 Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors (N=6), Sodium-Glucose co-Transporter-2 (SGLT2) Inhibitors (N=1) 
463 Sulphonylureas (N=1) and insulin (N=6) respectively. Combination therapy with Biguanide, DPP-IV-Inhibitor and 
464 SGLT-2-Inhibitor (N=1). ‡Monotherapy with GLP-1-antagonist (N=1). Combination therapy with GLP-1-antagonist 
465 and Biguanide (N=6) and insulin (N=2), respectively. §Numbers are given for those on insulin treatment.
466
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467 Table 2. Dietary analysis based on dietary records in early pregnancy by women with type 2 
468 diabetes and women with type 1 diabetes.
Type 2 diabetes Type 1 diabetes P-value
Number 96 108
Dietary records
 1 day 
 2 days 
 3 days
12 (12%)
15 (16%)
69 (72%)
32 (30%)
23 (21%)
53 (49%)
0.002
Carbohydrate consumption (g/day) 159 ±56 167 ±48 0.3
Carbohydrate consumption/kg bodyweight 
(g/kg/day)
1.9 ±0.9 2.3 ±0.8 <0.001
Consuming fewer carbohydrates than 
recommended by the Institute of Medicine†
50 (52%) 43 (40%) 0.08
Consuming <100 g of carbohydrates 10 (10%) 8 (7%) 0.5
The glycaemic index score‡§
 0-33%
 34-66%
 67-100%
13 (18%)
21 (30%)
37 (52%)
6 (6%)
36 (36%)
57 (58%)
0.04
Use of carbohydrate counting 6 (6%) 83 (77%) <0.001
Number of daily meals and snacks§
 ≥3 main meals 
 Snacks
o 3-4
o 2
o 0-1
74 (96%)
29 (38%)
17 (22%)
30 (40%)
75 (94%)
46 (58%)
22 (27%)
12 (15%)
0.7
0.002
469 Data are given as n (%) or mean ±standard deviation. Carbohydrates calculated from the major carbohydrate sources. 
470 †≤150 g daily. ‡A score of 67-100% means that the majority of recorded carbohydrates derived from low glycaemic 
471 index sources. §Data available from 74-92%.
472
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473 Table 3. Eating behaviour and lifestyle in pregnant women with type 2 or type 1 diabetes in early 
474 pregnancy. 
Type 2 diabetes Type 1 diabetes P-value
Number 54 42
Total physical activity (METs-h/wk.)†
 Household/caregiving
 Occupation
 Sports
 Other
215 (174-289)
85 (50-136)
71 (0-106)
11 (3-19)
49 (34-67)
210 (178-267)
57 (36-82)
81 (71-108)
10 (4-16)
63 (44-77)
0.9
0.002
0.06
0.9
0.02
Number of extra snacks eaten due to 
hypoglycaemia in the previous week
2 (0-6) 5.5 (3-8) 0.005
Changed eating behaviour due to nausea in the 
previous week
 Eating less due to nausea ≥1/wk.
 Number of times eating less due to 
nausea/wk.
 Eating more due to nausea ≥1/wk.
 Number of times eating more due to 
nausea/wk.
 Eating less or more due to nausea ≥1/wk.
Vomiting in the previous week
 Number of vomiting/wk.
24 (44%)
3 (1.5-6)
15 (29%)
3 (2-7)
29 (54%)
12 (23%)
2 (1-3)
19 (49%)
2 (1-5)
17 (41%)
6 (2-7)
27 (64%)
14 (34%)
1.5 (1-5)
0.7
0.4
0.2
0.3
0.3
0.2 
0.5
Number of blood glucose measurements/wk. 
before pregnancy
0.5 (0-5) 30 (7-50) <0.001
Number of blood glucose measurements in the 
previous week
48 (24-49) 60 (30-70) 0.001
Sleeping hours/24h in the previous week 7.7 ±1.3 7.9 ±1.0 0.5
475 Data are given as median (interquartile range), n (%) or mean ±standard deviation. Data available from 93-100%. 
476 †METs-h/wk.=metabolic equivalent of task per hour/week. 
477
